Comparing and Combining Alternative Strategies for Enhancing Cytochrome P450 Peroxygenase Activity

Cytochrome P450 monooxygenase (CYP) enzymes have advantageous properties over chemical catalysts. However, it is often not feasible to use CYPs in larger-scale synthesis as they require additional cofactors (NAD(P)H) and electron transfer proteins. This could be overcome by transforming CYPs into peroxygenases that use H2O2. Recently, multiple strategies have been reported for converting CYPs into peroxygenases. Mutating the residues of the acid–alcohol pair in the oxygen-binding groove to those found in natural peroxygenases can promote the desired H2O2-driven activity. Another strategy is to enlarge the enzyme’s solvent channels to allow H2O2 easier access into the active site, to enhance peroxygenase activity. Here, we evaluate these different strategies by comparing the peroxygenase activities of the double I-helix mutant D251Q/T252E (the QE mutant) and the F182A mutant of the bacterial enzyme CYP199A4. We also assess whether the peroxygenase activity can be further improved by combining these mutations (to give the F182AQE mutant). The F182A mutant exhibited the highest activity toward a selection of smaller substrates that undergo O-demethylation, S-oxidation, and epoxidation reactions. All the mutants converted 4-vinylbenzoic acid into the (S)-epoxide, with the F182A mutant having the highest stereoselectivity (>99% ee). The F182A mutant was unable to oxidize 4-t-butylbenzoic acid, while the F182AQE mutant could with high activity. The F182A mutation was found to substantially alter the selectivity of the reaction with 4-ethylbenzoic acid, increasing hydroxylation activity over desaturation. The F182A mutant catalyzed significant further oxidation reactions of the primary metabolites before all the substrate had been consumed, demonstrating a relaxed substrate specificity. X-ray crystal structures of the F182A and F182AQE mutants with the substrates revealed changes in substrate binding and solvent access providing insights into these experimental observations.

Authors

Institutions

Publication Details

Journal
ACS Catalysis
Published
2025-03-12
DOI
https://doi.org/10.1021/acscatal.4c07486
Citations
10
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
15.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparing and Combining Alternative Strategies for Enhancing Cytochrome P450 Peroxygenase Activity

Matthew N. Podgorski, Stephen G. Bell
10 citations
ACS Catalysis
Pharmacogenetics and Drug Metabolism
15.57
article

Comparing and Combining Alternative Strategies for Enhancing Cytochrome P450 Peroxygenase Activity

Matthew N. Podgorski, Stephen G. Bell
article en
10 citations

Abstract

Cytochrome P450 monooxygenase (CYP) enzymes have advantageous properties over chemical catalysts. However, it is often not feasible to use CYPs in larger-scale synthesis as they require additional cofactors (NAD(P)H) and electron transfer proteins. This could be overcome by transforming CYPs into peroxygenases that use H2O2. Recently, multiple strategies have been reported for converting CYPs into peroxygenases. Mutating the residues of the acid–alcohol pair in the oxygen-binding groove to those found in natural peroxygenases can promote the desired H2O2-driven activity. Another strategy is to enlarge the enzyme’s solvent channels to allow H2O2 easier access into the active site, to enhance peroxygenase activity. Here, we evaluate these different strategies by comparing the peroxygenase activities of the double I-helix mutant D251Q/T252E (the QE mutant) and the F182A mutant of the bacterial enzyme CYP199A4. We also assess whether the peroxygenase activity can be further improved by combining these mutations (to give the F182AQE mutant). The F182A mutant exhibited the highest activity toward a selection of smaller substrates that undergo O-demethylation, S-oxidation, and epoxidation reactions. All the mutants converted 4-vinylbenzoic acid into the (S)-epoxide, with the F182A mutant having the highest stereoselectivity (>99% ee). The F182A mutant was unable to oxidize 4-t-butylbenzoic acid, while the F182AQE mutant could with high activity. The F182A mutation was found to substantially alter the selectivity of the reaction with 4-ethylbenzoic acid, increasing hydroxylation activity over desaturation. The F182A mutant catalyzed significant further oxidation reactions of the primary metabolites before all the substrate had been consumed, demonstrating a relaxed substrate specificity. X-ray crystal structures of the F182A and F182AQE mutants with the substrates revealed changes in substrate binding and solvent access providing insights into these experimental observations.

ACS CatalysisVol. 15(6)
The University of Adelaide (AU)
University of Adelaide, Australian Research Council
Zero hunger
Openalex Percentile: Top 1%
Pharmacogenetics and Drug Metabolism
15.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.